A Medical Device Daily
Summer Street Research Partners, a healthcare-dedicated investment firm, reported that it served as exclusive U.S. placement agent in the £6.4 million ($9.08 million) capital raise for Lombard Medical Technologies (Didcot, UK) which closed on Tuesday.
Summer Street also served as Lombard's exclusive U.S. placement agent for the company's September 2008 capital raise.
Lombard develops stent grafts for the treatment of abdominal and thoracic aortic aneurysms, endovascular stapling devices for the fixation of stent grafts and percutaneous heart valves, and develops drug delivery coatings. The company was established in July 2000 and currently employs more than 100. It is listed on the London Stock Exchange under the symbol LMT.
SteadyMed (Tel Aviv) closed a $2 million round of funding from U.S. investors. The round was led by Samson Venture Partners, the investment management arm of Becker & Associates Consulting (Washington), a consulting firm specializing in medical devices and drugs.
SteadyMed, founded in 2005, develops miniature disposable infusion pumps with unique drug delivery characteristics that are designed to provide enhanced portability and optimized infusion algorithms for large molecules and high-viscosity drugs.
The company said it is targeting interest from several major pharma companies having biological drugs requiring the specialized drug-delivery characteristics enabled by its PatchPump technology. Prior investors in SteadyMed include the RAD Biomed Incubator, and its Chairman, Yehuda Zisapel.